Clemens Steinwender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Clemens Steinwender has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Hermann Blessberger
First Medical Department-Cardiology, Linz General Hospital, Johannes Kepler University School of Medicine Linz, Linz, Austria
8 shared publications Alexander Nahler
7 shared publications- Thomas Lambert
Department of Cardiology, Kepler University Hospital Linz, Johannes Kepler University Linz, Austria
7 shared publications Jürgen Kammler
Johannes Kepler Universität Linz
6 shared publicationsKarim Saleh
Johannes Kepler Universität Linz
6 shared publications- Alexander Kypta
1st Medical Department - Cardiology, Linz General Hospital, Johannes Kepler University School of Medicine Linz, Austria
5 shared publications
Latest Publications
- Open Access
- 19 November 2018
- Published by Springer Nature in Herzschrittmachertherapie + Elektrophysiologie
- Vol. 29 (4) , 334-339
Sondenloser Schrittmacher Micra™
- 19 November 2018
- Published by Springer Nature in Herzschrittmachertherapie + Elektrophysiologie
- Vol. 29 (4) , 334-339
Open AccessSondenloser Schrittmacher Micra™
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (11) , 1545-1548
Frequency of Renal Artery Stenosis After Renal Denervation in Patients With Resistant Arterial Hypertension
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (11) , 1545-1548
Frequency of Renal Artery Stenosis After Renal Denervation in Patients With Resistant Arterial Hypertension
- 29 May 2015
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 86 (3) , E126-E130
Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels
Renal denervation (RDN) is a promising treatment option in addition to medical antihypertensive treatment in patients suffering from resistant hypertension. Despite the growing interest in RDN, the negative result of the Symplicity HTN-3 trial led to a debate on the efficacy of RDN. We systematically investigated the effects of RDN, evaluated by 24-hr ambulatory blood pressure measurements (ABPM), in a consecutive series of patients with resistant hypertension, which was defined by a mean office systolic blood pressure (SBP) >160 mm Hg (>150 mm Hg in patients with diabetes). Patients with a mean 24-hr SBP of less than 130 mm Hg at baseline were classified as pseudo-resistant, while all other patients were classified as true-resistant. After six months, we analyzed the response rates in true-resistant and in pseudo-resistant patients, respectively, by the means of 24-hr ABPM. Thereby, patients with a reduction of more than 5 mm Hg in 24-hr SBP were classified as responders. RDN was performed in 106 patients. By 24-hr ABPM, 20 patients (18.9%) were classified as pseudo-resistant patients. In this cohort, we only found two responders (response rate 10%) six months after RDN. By contrast, in true-resistant patients, the response rate was almost 60% and the mean BP reduction was −18.6/−9 mm Hg in 24-hr ABPM. We found a significant BP reduction in almost 60% of patients with true-resistant hypertension, but only in 10% in patients with pseudo-resistant hypertension. According to our results, patient selection seems to be crucial for acceptable response rates after RDN.
- 29 May 2015
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 86 (3) , E126-E130
Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels
Renal denervation (RDN) is a promising treatment option in addition to medical antihypertensive treatment in patients suffering from resistant hypertension. Despite the growing interest in RDN, the negative result of the Symplicity HTN-3 trial led to a debate on the efficacy of RDN. We systematically investigated the effects of RDN, evaluated by 24-hr ambulatory blood pressure measurements (ABPM), in a consecutive series of patients with resistant hypertension, which was defined by a mean office systolic blood pressure (SBP) >160 mm Hg (>150 mm Hg in patients with diabetes). Patients with a mean 24-hr SBP of less than 130 mm Hg at baseline were classified as pseudo-resistant, while all other patients were classified as true-resistant. After six months, we analyzed the response rates in true-resistant and in pseudo-resistant patients, respectively, by the means of 24-hr ABPM. Thereby, patients with a reduction of more than 5 mm Hg in 24-hr SBP were classified as responders. RDN was performed in 106 patients. By 24-hr ABPM, 20 patients (18.9%) were classified as pseudo-resistant patients. In this cohort, we only found two responders (response rate 10%) six months after RDN. By contrast, in true-resistant patients, the response rate was almost 60% and the mean BP reduction was −18.6/−9 mm Hg in 24-hr ABPM. We found a significant BP reduction in almost 60% of patients with true-resistant hypertension, but only in 10% in patients with pseudo-resistant hypertension. According to our results, patient selection seems to be crucial for acceptable response rates after RDN.
- 1 January 2015
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 56 (6) , 679-681
Coronary Pan-Ischemia as a First Sign of a Fulminant Host-Versus-Graft Reaction Eight Years After Orthotopic Heart Transplantation
Acute graft rejection in patients after heart transplantation can cause arrhythmias and acute angina pectoris with electrocardiographic ST-segment elevation. We report a case of a 53-year old female patient who had undergone cardiac transplantation 8 years previously. She developed bradycardia with co-existent ST-segment elevation caused by a histologically proven acute graft rejection. After administration of methylprednisolone and immune absorption leading to initial clinical improvement, the patient died unexpectedly. The reasons remain unclear, but a degeneration of the conduction system as well as impaired blood flow in the right coronary caused by cellular and humoral rejection most likely have both contributed.
- 1 January 2015
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 56 (6) , 679-681
Coronary Pan-Ischemia as a First Sign of a Fulminant Host-Versus-Graft Reaction Eight Years After Orthotopic Heart Transplantation
Acute graft rejection in patients after heart transplantation can cause arrhythmias and acute angina pectoris with electrocardiographic ST-segment elevation. We report a case of a 53-year old female patient who had undergone cardiac transplantation 8 years previously. She developed bradycardia with co-existent ST-segment elevation caused by a histologically proven acute graft rejection. After administration of methylprednisolone and immune absorption leading to initial clinical improvement, the patient died unexpectedly. The reasons remain unclear, but a degeneration of the conduction system as well as impaired blood flow in the right coronary caused by cellular and humoral rejection most likely have both contributed.
- 29 December 2014
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 30 (2) , 217
Erosion of a Dual-Chamber Pacemaker System
- 29 December 2014
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 30 (2) , 217
Erosion of a Dual-Chamber Pacemaker System